Fumihiko Takeshita

Daiichi Sankyo Co., Ltd.

April 2018– Vice President, Vaccine Research Laboratories, Daiichi Sankyo Co., Ltd.

April 2017– Senior Director, Vaccine Business Oversight Department, and Leader, Adjuvant Initiative Unit, Daiichi Sankyo Co., Ltd. Vice President, Vaccine Research Laboratories, Kitasato Daiichi Sankyo Vaccine Co., Ltd.

Leading & Management of vaccine research & development projects including the public-private partnership projects based on national program, JST NexTEP (adjuvant), AMED CiCLE (genetic vaccine), AMED "Fundamental Research on the Control of a Novel Coronavirus (2019-nCoV)", and AMED "Drug Discovery Support Program “Development of a Vaccine for COVID-19 Vaccines (Second Round)".